{"transactions":[{"id":1565719,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-20T16:15:10.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 18, 2024 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of March 18, 2024. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":400000,"derivative":{"exercise_price":10.12,"expiration_date":"2034-03-17","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000950170-24-034177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572002/000095017024034177/ownership.xml","form_type":"4"}},{"id":2535425,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-25T18:41:50.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":95,"price":28.83,"value":2738.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $28.9187, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 5,292 shares of common stock and 7,063 restricted stock units."}],"balance_after":12355,"source":{"system":"sec-edgar","filing":"0001209191-21-061561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919121061561/doc4.xml","form_type":"4"}},{"id":2624751,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-26T16:06:07.000Z","date":"2021-07-22","kind":"sale","acquired":false,"shares":90,"price":34.13,"value":3071.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 5,075 shares of common stock and 7,375 restricted stock units. Includes 647 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the \"ESPP\") on May 31, 2021."}],"balance_after":12450,"source":{"system":"sec-edgar","filing":"0001209191-21-048161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919121048161/doc4.xml","form_type":"4"}},{"id":2739433,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-26T18:10:06.000Z","date":"2021-04-22","kind":"sale","acquired":false,"shares":90,"price":31.75,"value":2857.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 4,205 shares of common stock and 7,688 restricted stock units. Includes 940 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the \"ESPP\") on May 31, 2019, 13 shares of common stock acquired under the ESPP on November 30, 2019, and 1,205 shares of common stock acquired under the ESPP on May 31, 2020."}],"balance_after":11893,"source":{"system":"sec-edgar","filing":"0001209191-21-028377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919121028377/doc4.xml","form_type":"4"}},{"id":2897454,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-25T17:37:27.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":23700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025."}],"balance_after":23700,"derivative":{"exercise_price":34.88,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":23700},"source":{"system":"sec-edgar","filing":"0001209191-21-005154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919121005154/doc4.xml","form_type":"4"}},{"id":2897453,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-25T17:37:27.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":110,"price":34.62,"value":3808.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents 1,825 shares of common stock and 8,000 restricted stock units."}],"balance_after":9825,"source":{"system":"sec-edgar","filing":"0001209191-21-005154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919121005154/doc4.xml","form_type":"4"}},{"id":2897452,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-25T17:37:27.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 21, 2022, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2022 and ending on January 21, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 1,622 shares of common stock and 8,313 restricted stock units. Includes 150 shares of common stock acquired under the Albireo\nPharma, Inc. 2018 Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":9935,"source":{"system":"sec-edgar","filing":"0001209191-21-005154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919121005154/doc4.xml","form_type":"4"}},{"id":3000535,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-10-23T16:21:03.000Z","date":"2020-10-22","kind":"sale","acquired":false,"shares":89,"price":34.55,"value":3074.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 1,472 shares of common stock and 2,813 restricted stock units."}],"balance_after":4285,"source":{"system":"sec-edgar","filing":"0001209191-20-055676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919120055676/doc4.xml","form_type":"4"}},{"id":3076800,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-23T16:15:10.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":91,"price":25.8,"value":2347.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 1,249 shares of common stock and 3,125 restricted stock units."}],"balance_after":4374,"source":{"system":"sec-edgar","filing":"0001209191-20-043473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919120043473/doc4.xml","form_type":"4"}},{"id":3170095,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-24T17:22:10.000Z","date":"2020-04-22","kind":"sale","acquired":false,"shares":92,"price":17.64,"value":1622.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 1,027 shares of common stock and 3,438 restricted stock units."}],"balance_after":4465,"source":{"system":"sec-edgar","filing":"0001209191-20-025646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919120025646/doc4.xml","form_type":"4"}},{"id":3303830,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-23T19:28:21.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests as to 25% of the shares on January 21, 2021, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2021 and ending on January 21, 2024, provided that the vesting of the option may be accelerated, in whole or in part, based on the achievement of certain pre-established company performance criteria, but in no event prior to January 21, 2021."}],"balance_after":31500,"derivative":{"exercise_price":24.67,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-20-004742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919120004742/doc4.xml","form_type":"4"}},{"id":3303829,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-23T19:28:21.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":443,"price":24.29,"value":10760.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 807 shares of common stock and 3,750 restricted stock units."}],"balance_after":4557,"source":{"system":"sec-edgar","filing":"0001209191-20-004742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919120004742/doc4.xml","form_type":"4"}},{"id":3687867,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T18:48:07.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023."}],"balance_after":23000,"derivative":{"exercise_price":24.04,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-19-005241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919119005241/doc4.xml","form_type":"4"}},{"id":3687866,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-24T18:48:07.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-005241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919119005241/doc4.xml","form_type":"4"}},{"id":3849510,"issuer":{"id":116015,"kind":"organization","name":"ALBIREO PHARMA, INC.","symbol":"ALBO"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-08T16:14:12.000Z","date":"2018-08-06","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable as to 25% of the underlying shares on August 6, 2019 and the remainder in equal quarterly installments through the fourth anniversary of the date of grant."}],"balance_after":37500,"derivative":{"exercise_price":31.54,"expiration_date":"2028-08-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-18-045819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1322505/000120919118045819/doc4.xml","form_type":"4"}},{"id":4281950,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-14T16:07:59.000Z","date":"2017-06-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":47689,"derivative":{"exercise_price":2.03,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-039812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373707/000120919117039812/doc4.xml","form_type":"4"}},{"id":4281949,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-06-14T16:07:59.000Z","date":"2017-06-13","kind":"exercise","acquired":true,"shares":10000,"price":2.03,"value":20300.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-17-039812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1373707/000120919117039812/doc4.xml","form_type":"4"}},{"id":4473189,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-01T18:13:04.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests as to 6.25% of the shares on 4/30/2017 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/30/2021."}],"balance_after":140000,"derivative":{"exercise_price":3.69,"expiration_date":"2027-01-29","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-17-006849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1373707/000120919117006849/doc4.xml","form_type":"4"}},{"id":4473188,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":92811,"kind":"person","name":"Horn Patrick Taylor","position":1,"cik":"0001572002","reported_name":"Horn Patrick Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-02-01T18:13:04.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on January 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on January 31, 2020."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-006849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1373707/000120919117006849/doc4.xml","form_type":"4"}}]}